CaMK4 is a kinase that contributes to the excessive production of IL-17 in lymphatic tissues and kidneys, leading to the mediation of pathological T cell activity and the development of lupus nephritis (LN), which is one of the most common clinical forms of SLE. This evidence concerns the gene IL17A and systemic lupus erythematosus.